Correction: Effectiveness and Tolerability of Low-Dose Micronized Isotretinoin in Patients with Severe Recalcitrant Nodular Facial Acne in India: A Real-World Retrospective Study Using Electronic Medical Records - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Efficacy and Safety of Low-Dose Micronized Isotretinoin in Patients Suffering from Severe Recalcitrant Nodular Acne on the Face in India: A Retrospective Study Utilizing Electronic Medical Records

  • By

  • Byalakere S. Chandrashekar

  • Maya Vedamurthy

  • Seetharamanjaneyulu Kolalapudi

  • Vijaya Bhaskar Mallela

  • Shahnaz Arsiwala

  • Anil Ganjoo

  • Abir Saraswat

  • Farida Modi

  • Sowmya C. Sujatha

  • Satish Udare

  • Surajit Gorai

  • Mukesh Gabhane

  • Bhavesh Lalan

  • Gaurang Jani

  • Aditi Jain

  • Shruti Dharmadhikari

  • Chintan Khandhedia

  • Prashant Devkare

  • Amey Mane

  • Asif Shaikh

  • Suyog Mehta

  • September 5, 2026

Share

Clinical Scorecard: Correction: Efficacy and Safety of Low-Dose Micronized Isotretinoin in Patients Suffering from Severe Recalcitrant Nodular Acne on the Face in India: A Retrospective Study Utilizing Electronic Medical Records

At a Glance

CategoryDetail
ConditionSevere Recalcitrant Nodular Acne
Key MechanismsMicronized Isotretinoin
Target PopulationPatients with severe recalcitrant nodular acne
Care SettingRetrospective study utilizing electronic medical records

Key Highlights

  • Correction of author names in the original article
  • Focus on low-dose micronized isotretinoin
  • Study conducted in India

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients suffering from severe recalcitrant nodular acne

          Low-dose micronized isotretinoin

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Effectiveness and Tolerability of Low-Dose Micronized Isotretinoin in Patients with Severe Recalcitrant Nodular Facial Acne in India: A Real-World Retrospective Study Using Electronic Medical Records

            • by Byalakere S. Chandrashekar, Maya Vedamurthy, Seetharamanjaneyulu Kolalapudi, Vijaya Bhaskar Mallela, Shahnaz Arsiwala, Anil Ganjoo, Abir Saraswat, Farida Modi, Sowmya C. Sujatha, Satish Udare, Surajit Gorai, Mukesh Gabhane, Bhavesh Lalan, Gaurang Jani, Aditi Jain, Shruti Dharmadhikari, Chintan Khandhedia, Prashant Devkare, Amey Mane, Asif Shaikh, Suyog Mehta

            • September 5, 2026

            Related Content

            Cellulitis-like cutaneous cryptococcosis revealing disseminated infection in a kidney transplant recipient: a case report and systematic review

            Correction: Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features

            FDA monthly preview: Key September decisions to watch

            Several FDA decisions across multiple specialties are expected this month.